Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
European Radiology
Erschienen in: European Radiology 7/2004

01.07.2004 | Hepatobiliary-Pancreas

Cross-sectional imaging of biliary tumors: current clinical status and future developments

verfasst von: Christoph J. Zech, Stefan O. Schoenberg, Maximilian Reiser, Thomas Helmberger

Erschienen in: European Radiology | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

Extrahepatic cholangiocarcinoma, including hilar cholangiocarcinoma, is a relatively rare diagnosis. However, it frequently has been associated with major problems in diagnostics and clinical management from its first comprehensive description by Klatskin up until today. In this article, cholangiocarcinoma, representing the most common biliary tumor, as well as the differential diagnoses of benign and malignant biliary obstruction, will be discussed. The latest improvements of cross-sectional imaging modalities (sonography, CT, MRI and PET) and their diagnostic values for detection and staging will be displayed. A practical imaging-based diagnostic approach to obstructive biliary disease will be proposed.
Literatur
1.
Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological. Am J Med 38:241–256
2.
Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics (2000). CA Cancer J Clin 50:7–33PubMed
3.
4.
Lim JH, Kim MH, Kim TK et al (2003) Papillary neoplasms of the bile duct that mimic biliary stone disease. Radiographics 23:447–455PubMed
5.
Levy AD, Murakata LA, Abbott RM, Rohrmann CA Jr (2002) From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Radiographics 22:387–413PubMed
6.
Knoefel WT, Prenzel KL, Peiper M et al (2003) Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol 29:658–661CrossRefPubMed
7.
Inaba K, Suzuki S, Yokoi Y et al (2003) Hepatic inflammatory pseudotumor mimicking intrahepatic cholangiocarcinoma: report of a case. Surg Today 33:714–717CrossRefPubMed
8.
Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178PubMed
9.
Han JK, Choi BI, Kim AY et al (2002) Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 22:173–187PubMed
10.
Braga HJ, Imam K, Bluemke DA (2001) MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. Am J Roentgenol 177:111–114
11.
Maetani Y, Itoh K, Watanabe C et al (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. Am J Roentgenol 176:1499–1507
12.
Kim JH, Kim MJ, Chung JJ, Lee WJ, Yoo HS, Lee JT (2002) Differential diagnosis of periampullary carcinomas at MR imaging. Radiographics 22:1335–1352PubMed
13.
Tannapfel A, Wittekind C (2001) Anatomy and pathology of intrahepatic and extrahepatic bile duct tumors. Pathologe 22:114–123CrossRefPubMed
14.
Manfredi R, Masselli G, Maresca G, Brizi MG, Vecchioli A, Marano P (2003) MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 28:319–325CrossRefPubMed
15.
Cha JH, Han JK, Kim TK et al (2000) Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability. Abdom Imaging 25:500–507CrossRefPubMed
16.
Lygidakis NJ, Sgourakis GJ, Dedemadi GV, Vlachos L, Safioleas M (2001) Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience. Hepatogastroenterology 48:95–101
17.
Bathe OF, Pacheco JT, Ossi PB et al (2001) Management of hilar bile duct carcinoma. Hepatogastroenterology 48:1289–1294
18.
Khan SA, Davidson BR, Goldin R et al (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51[Suppl 6]:VI 1–9
19.
Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
20.
Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193:384–391CrossRefPubMed
21.
Courbiere M, Pilleul F, Henry L, Ponchon T, Touzet S, Valette PJ (2003) Value of magnetic resonance cholangiography in benign and malignant biliary stenosis: comparative study with direct cholangiography. J Comput Assist Tomogr 27:315–320
22.
Yeh TS, Jan YY, Tseng JH et al (2000) Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 95:432–440PubMed
23.
Moon SG, Han JK, Kim (2003) Biliary obstruction in metastatic disease: thin-section helical CT findings. Abdom Imaging 28:45–52CrossRefPubMed
24.
Mulholland MW, Yahanda A, Yeo CJ (2001) Multidisciplinary management of perihilar bile duct cancer. J Am Coll Surg 193:440–447CrossRefPubMed
25.
Masci E, Toti G, Mariani A et al (2001) Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417–423PubMed
26.
Rosch T, Meining A, Fruhmorgen S et al (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55:870–876CrossRefPubMed
27.
Burtin P, Palazzo L, Canard JM, Person B, Oberti F, Boyer J (1997) Diagnostic strategies for extrahepatic cholestasis of indefinite origin: endoscopic ultrasonography or retrograde cholangiography? Results of a prospective study. Endoscopy 29:349–355PubMed
28.
Ponchon T (2000) Diagnostic endoscopic retrograde cholangiopancreatography. Endoscopy 32:200–208CrossRefPubMed
29.
Bloom CM, Langer B, Wilson SR (1999) Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 19:1199–1218PubMed
30.
Itoh S, Ikeda M, Ota T, Satake H, Takai K, Ishigaki T (2003) Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol 13:277–285PubMed
31.
Fletcher JG, Wiersema MJ, Farrell MA et al (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90PubMed
32.
Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH (1998) Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. Am J Roentgenol 171:651–658PubMed
33.
Nesbit GM, Johnson CD, James EM, MacCarty RL, Nagorney DM, Bender CE (1988) Cholangiocarcinoma:diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. Am J Roentgenol 151:933–938
34.
Gulliver DJ, Baker ME, Cheng CA, Meyers WC, Pappas TN (1992) Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability. Am J Roentgenol 159:503–507
35.
Feydy A, Vilgrain V, Denys A et al (1999) Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Am J Roentgenol 172:73–77
36.
Campbell WL, Peterson MS, Federle MP et al (2001) Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis. Am J Roentgenol 177:1095–1100
37.
Ochotorena IJ, Kiyosue H, Hori Y, Yokoyama S, Yoshida T, Mori H (2000) The local spread of lower bile duct cancer: evaluation by thin-section helical CT. Eur Radiol 10:1106–1113CrossRefPubMed
38.
Van Beers BE, Lacrosse M, Trigaux JP, de Canniere L, De Ronde T, Pringot J (1994) Noninvasive imaging of the biliary tree before or after laparoscopic cholecystectomy: use of three-dimensional spiral CT cholangiography. Am J Roentgenol 162:1331–1335
39.
Greenberg M, Greenberg BM, Rubin JM, Greenberg IM (1982) Computed-tomographic cholangiography: a new technique for evaluating the head of the pancreas and distal biliary tree. Radiology 144:363–368PubMed
40.
Zandrino F, Benzi L, Ferretti ML, Ferrando R, Reggiani G, Musante F (2002) Multislice CT cholangiography without biliary contrast agent: technique and initial clinical results in the assessment of patients with biliary obstruction. Eur Radiol 12:1155–1161CrossRefPubMed
41.
Maniatis P, Triantopoulou C, Sofianou E et al (2003) Virtual CT cholangiography in patients with choledocholithiasis. Abdom Imaging 28:536–544CrossRefPubMed
42.
Caoili EM, Paulson EK, Heyneman LE, Branch MS, Eubanks WS, Nelson RC (2000) Helical CT cholangiography with three-dimensional volume rendering using an oral biliary contrast agent: feasibility of a novel technique. Am J Roentgenol 174:487–492
43.
Fulcher AS, Turner MA (1997) HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. Am J Roentgenol 169:1501–1505
44.
Hundt W, Petsch R, Scheidler J, Reiser M (2002) Clinical evaluation of further-developed MRCP sequences in comparison with standard MRCP sequences. Eur Radiol 12:1768–1777PubMed
45.
Prassopoulos P, Papanikolaou N, Maris T, Gogas C, Mouzas J, Gourtsoyiannis N (2002) Development of contrast-enhanced virtual MR cholangioscopy: a feasibility study. Eur Radiol 12:1438–1441PubMed
46.
Ba-Ssalamah A, Heinz-Peer G, Schima W et al (2000) Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 11:665–672PubMed
47.
Lee SS, Kim MH, Lee SK et al (2002) MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. Gastrointest Endosc 56:25–32PubMed
48.
Lopera JE, Soto JA, Munera F (2001) Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 220:90–96PubMed
49.
Pavone P, Laghi A, Catalano C, Panebianco V, Fabiano S, Passariello R (1999) MRI of the biliary and pancreatic ducts. Eur Radiol 9:1513–1522CrossRefPubMed
50.
Holzknecht N, Gauger J, Sackmann M et al (1998) Breath-hold MR cholangiography with snapshot techniques: prospective comparison with endoscopic retrograde cholangiography. Radiology 206:657–664PubMed
51.
Wiedmann M, Caca K, Berr F et al (2003) Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97:2783–2790CrossRefPubMed
52.
Lee MG, Park KB, Shin YM et al (2003) Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg 27:278–283CrossRefPubMed
53.
Smedby O, Riesenfeld V, Karlson B et al (1997) Magnetic resonance angiography in the resectability assessment of suspected pancreatic tumours. Eur Radiol 7:649–653PubMed
54.
Catalano C, Pavone P, Laghi A et al (1998) Pancreatic adenocarcinoma: combination of MR imaging, MR angiography and MR cholangiopancreatography for the diagnosis and assessment of resectability. Eur Radiol 8:428–434PubMed
55.
Fritscher-Ravens A, Bohuslavizki KH, Broering DC et al (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277–1285CrossRefPubMed
56.
Keiding S, Hansen SB, Rasmussen HH et al (1998) Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28:700–706PubMed
57.
Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD (2003) Usefulness of (18)F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467–1472CrossRefPubMed
Metadaten
Titel
Cross-sectional imaging of biliary tumors: current clinical status and future developments
verfasst von
Christoph J. Zech
Stefan O. Schoenberg
Maximilian Reiser
Thomas Helmberger
Publikationsdatum
01.07.2004
Erschienen in
European Radiology / Ausgabe 7/2004
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-004-2327-z

Weitere Artikel der Ausgabe 7/2004

European Radiology 7/2004 Zur Ausgabe

Chest

Pulmonary embolism findings on chest radiographs and multislice spiral CT

Interpretation Corner

17-year-old boy with non-productive cough (2004:7a)

Head and Neck

Change of sonographic findings on cervical lymph nodes before and after preoperative radiotherapy

Experimental

Adenosine A1 receptors in contrast media-induced renal dysfunction in the normal rat

Experimental

Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver

Physics

Assessment of a theoretical formalism for dose estimation in CT: an anthropomorphic phantom study

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise